BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29507312)

  • 1. Analysis of the oligomeric states of nucleophosmin using size exclusion chromatography.
    Sakashita G; Kiyoi H; Naoe T; Urano T
    Sci Rep; 2018 Mar; 8(1):4008. PubMed ID: 29507312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural polymorphism in the N-terminal oligomerization domain of NPM1.
    Mitrea DM; Grace CR; Buljan M; Yun MK; Pytel NJ; Satumba J; Nourse A; Park CG; Madan Babu M; White SW; Kriwacki RW
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4466-71. PubMed ID: 24616519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization and efficient detection of Nucleophosmin/NPM1 oligomers.
    Lin J; Hisaoka M; Nagata K; Okuwaki M
    Biochem Biophys Res Commun; 2016 Nov; 480(4):702-708. PubMed ID: 27983985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic conformations of nucleophosmin (NPM1) at a key monomer-monomer interface affect oligomer stability and interactions with granzyme B.
    Duan-Porter WD; Woods VL; Maurer KD; Li S; Rosen A
    PLoS One; 2014; 9(12):e115062. PubMed ID: 25490769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
    Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
    ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
    Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
    Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
    Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
    FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.
    Federici L; Arcovito A; Scaglione GL; Scaloni F; Lo Sterzo C; Di Matteo A; Falini B; Giardina B; Brunori M
    J Biol Chem; 2010 Nov; 285(48):37138-49. PubMed ID: 20858903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
    Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
    Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling.
    Okuwaki M; Sumi A; Hisaoka M; Saotome-Nakamura A; Akashi S; Nishimura Y; Nagata K
    Nucleic Acids Res; 2012 Jun; 40(11):4861-78. PubMed ID: 22362753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the unstructured N-terminal domain of the hAPE1 (human apurinic/apyrimidinic endonuclease 1) in the modulation of its interaction with nucleic acids and NPM1 (nucleophosmin).
    Poletto M; Vascotto C; Scognamiglio PL; Lirussi L; Marasco D; Tell G
    Biochem J; 2013 Jun; 452(3):545-57. PubMed ID: 23544830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomers of human histone chaperone NPM1 alter p300/KAT3B folding to induce autoacetylation.
    Kaypee S; Sahadevan SA; Sudarshan D; Halder Sinha S; Patil S; Senapati P; Kodaganur GS; Mohiyuddin A; Dasgupta D; Kundu TK
    Biochim Biophys Acta Gen Subj; 2018 Aug; 1862(8):1729-1741. PubMed ID: 29746960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
    Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
    FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-quadruplex DNA recognition by nucleophosmin: new insights from protein dissection.
    Scognamiglio PL; Di Natale C; Leone M; Poletto M; Vitagliano L; Tell G; Marasco D
    Biochim Biophys Acta; 2014 Jun; 1840(6):2050-9. PubMed ID: 24576674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies to synthetic fragments of nucleophosmin for the specific detection of its monomeric and oligomeric forms].
    Shalgunov VS; Lobanova NV; Bulycheva TI; Deĭneko nL; Volkova TD; Filatova MP; Kamynina AV; Kim IaS; Vladimirova NV; Koroev DO; Akhidova EV; Vol'pina OM
    Bioorg Khim; 2009; 35(6):799-807. PubMed ID: 20208579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
    Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
    Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of multifunctional nucleolar protein nucleophosmin (NPM1) by aurora kinase B is critical for mitotic progression.
    Shandilya J; Senapati P; Dhanasekaran K; Bangalore SS; Kumar M; Kishore AH; Bhat A; Kodaganur GS; Kundu TK
    FEBS Lett; 2014 Jun; 588(14):2198-205. PubMed ID: 24857377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of CacyBP/SIP with NPM1 and its influence on NPM1 localization and function in oxidative stress.
    Rosińska S; Filipek A
    J Cell Physiol; 2018 Nov; 233(11):8826-8838. PubMed ID: 29806702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
    Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
    Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the recognition by 14-3-3 proteins of a conditional binding site within the oligomerization domain of human nucleophosmin.
    Kapitonova AA; Tugaeva KV; Varfolomeeva LA; Boyko KM; Cooley RB; Sluchanko NN
    Biochem Biophys Res Commun; 2022 Oct; 627():176-183. PubMed ID: 36041327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.